• 2139 Citations
  • 23 h-Index
19942019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Willem H. van Harten is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 97 Similar Profiles
Cost-Benefit Analysis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Exercise Medicine & Life Sciences
Biomedical Technology Assessment Medicine & Life Sciences
Netherlands Medicine & Life Sciences
Survivors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Adherence to and satisfaction with low-intensity physical activity and supervised moderate-high intensity exercise during chemotherapy for breast cancer

van Waart, H., Buffart, L. M., Stuiver, M. M., van Harten, W. H., Sonke, G. S. & Aaronson, N. K., 8 Aug 2019, In : Supportive care in cancer.

Research output: Contribution to journalArticleAcademicpeer-review

Exercise
Breast Neoplasms
Drug Therapy
Patient Satisfaction
Self Report

Cost effectiveness of interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer on the basis of a randomized phase III trial

Koole, S. N., Van Lieshout, C., Van Driel, W. J., Van Schagen, E., Sikorska, K., Kieffer, J. M., Schagen van Leeuwen, J. H., Schreuder, H. W. R., Hermans, R. H., De Hingh, I. H., Van Der Velden, J., Arts, H. J., Massuger, L. F. A. G., Aalbers, A. G., Verwaal, V. J., Van De Vijver, K. K., Aaronson, N. K., Van Tinteren, H., Sonke, G. S., Van Harten, W. H. & 1 othersRetèl, V. P., 10 Aug 2019, In : Journal of clinical oncology. 37, 23, p. 2041-2050 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Ovarian Neoplasms
Cost-Benefit Analysis
Quality-Adjusted Life Years
Drug Therapy
Costs and Cost Analysis
1 Citation (Scopus)
6 Downloads (Pure)

Impact of organ-on-a-chip technology on pharmaceutical R&D costs

Franzen, N., van Harten, W. H., Retèl, V. P., Loskill, P., van den Eijnden-van Raaij, J. & IJzerman, M., 8 Jun 2019, In : Drug discovery today.

Research output: Contribution to journalShort surveyAcademicpeer-review

Open Access
File
Pharmaceutical Technology
Costs and Cost Analysis
Technology
Drug Costs
Drug Discovery
2 Downloads (Pure)

Implementing physical activity programs for patients with cancer in current practice: patients’ experienced barriers and facilitators

IJsbrandy, C., Hermens, R. P. M. G., Boerboom, L. W. M., Gerritsen, W. R., van Harten, W. H. & Ottevanger, P. B., 25 Dec 2019, In : Journal of cancer survivorship.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Exercise
Neoplasms
Organizations
Delivery of Health Care
Survivors
9 Downloads (Pure)

Patient access to voice prostheses and heat and moisture exchangers: Factors influencing physician's prescription and reimbursement in eight European countries

Beck, A. C. C., Retèl, V. P., van den Brekel, M. W. M. & van Harten, W. H., 1 Apr 2019, In : Oral Oncology. 91, p. 56-64 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
Artificial Larynges
Prescriptions
Hot Temperature
Physicians
Equipment and Supplies

Activities 2015 2015

  • 1 Oral presentation

Alliantie Regionale Topzorg

Willem H. van Harten (Speaker)
4 Mar 2015

Activity: Talk or presentationOral presentation